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ABSTRACT 
 
     Heart failure and high mortality rates are associated with severe sepsis. 
Recently, focus has been on mitochondrial ultrastructural changes and function 
due to sepsis and sepsis-related pathologies. Chopra et al. (2011) has provided 
data showing the involvement of the mitochondrial-mediated intrinsic apoptosis 
cascade in regulating adult rat ventricular myocyte (ARVM) dysfunction in sepsis. 
Experimental endotoxemia has shown mitochondrial membrane potential 
collapse, membrane permeability changes and release of cytochrome C to be 
indicators of mitochondrial dysfunction. Outer mitochondrial membrane (OMM) 
permeability is controlled by Bax translocation, resulting Voltage Dependent 
Anion Channels (VDACs) pores in the OMM and activation of mitoKATP channels 
in the inner mitochondrial membrane. Endotoxins can induce mitochondrial 
damage and there is a correlation between the severity of sepsis and 
mitochondrial damage and dysfunction. Since the progression of sepsis occurs 
from vascular dysfunction to organ dysfunction, in the current study we examined 
mitochondrial dysfunction in endotoxic HUVEC cells. This study has provided 
evidence for 5HD, a putative mitoKATP blocker, in the preservation of ∆Ψm in 
endotoxic HUVEC. Additionally, 5HD appears to prevent Apaf-1 expression and 
reduce H2O2 generation in endotoxic HUVEC. 
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INTRODUCTION 
Mitochondria: An Energy Source for Cells  
     Mitochondria serve as a significant source of energy for cells due to the 
considerable amounts of ATP produced during aerobic respiration. Mitochondria 
facilitate the use of oxygen by cells to generate large quantities of ATP compared 
to lower amounts under anaerobic conditions. Energy sources such as 
carbohydrates, lipids and proteins are broken down through the process of 
glycolysis which produces two molecules of ATP per one event of glycolysis 
under anaerobic conditions and lactic acid accumulation (5). However, under 
aerobic states, cells further oxidize these energy sources through the citric acid 
cycle to generate electron carriers such as NADPH and FADH2. Mitochondria 
enable the use of these electron carriers to produce over thirty ATP molecules 
through the process of oxidative phosphorylation.  
      An electron transport chain (ETC) also exists along the inner mitochondrial 
membrane (IMM). The ETC serves to generate ATP through electron donation 
from electron carriers NADH and FADH2 and formation of a proton gradient 
across the IMM (34). Four protein complexes form the ETC to shuttle electrons 
donated by NADH and FADH2, three of which also transport protons across the 
IMM into the intermembrane space: complexes I, III and IV (34), (44). Transport 
of electrons from NADH and FADH2 to ubiquinone, or coenzyme Q, is 
accomplished by complex I (NADH/ubiquinone oxidoreductase) and complex II,  
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respectively. Electrons are then transported from ubiquinone to complex III and 
from complex III to IV by cytochrome C to ultimately reduce molecular oxygen to 
water. Protons are simultaneously transferred with electron transport from the 
mitochondrial matrix to the intermembrane space by complex I, III and IV. It is the 
influx of protons from the intermembrane space into the mitochondrial matrix 
through ATP synthase which provides the energy for ATP production by 
mitochondria. This ATP can either remain in the mitochondrial matrix or be 
transported into the intermembrane space by an adenine nucleotide translocator 
(ANT) and into the cytoplasm by a voltage-dependent anion channel (VDAC) 
located in the outer mitochondrial membrane (OMM) (44),(5). 
 
Mitochondria: Significance in Pathogenic Disorders  
     Mitochondrial dysfunction contributes to several physiological disorders due to 
the essential role in energy supply. Normal mitochondrial activity produces 
harmful compounds and the balance between generation and neutralization of 
these compounds is fundamental. Mechanisms exist in mitochondria to maintain 
stability in the presence of various by-products; however, distinct pathologies can 
have deleterious effects on these mechanisms. However, mitochondria also have 
many other functions in addition to energy production. For example, specific 
mitochondrial enzymes exist to act as defense mechanisms which are also 
susceptible to disruption. Defects in mitochondrial function and associated  
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pathologies can cause oxidative stress and metabolic disorders in addition to a 
diminished supply of ATP.  
 
Mitochondria and Diabetic Cardiomyopathy 
     Diabetic cardiomyopathy can be characterized by left ventricular dysfunction 
and hypertrophy in diabetic individuals (69). Cardiac contractility diminishes due 
to the influence of pathological morphological and functional changes which 
occur in the heart in diabetic cardiomyopathy. Zhang et al. have provided 
evidence of mitochondrial ultrastructural alterations in mitochondria isolated from 
cardiac tissue of a murine model of type 1 diabetes, as well as demonstrated 
disrupted mitochondrial membrane potential (ΔΨM) in cardiomyocytes exposed to 
high levels of glucose (71). Moreover, it is mitochondria-derived ATP through 
oxidative phosphorylation which supplies the majority of the energy required for 
cardiac function (22). Up to 70% of the total ATP received is used for contraction 
of cardiac myocytes alone (22). The bioenergetics of cardiac physiology requires 
a substantial and consistent supply of ATP which is limited in diabetic individuals. 
Insulin is responsible for the insertion of glucose transporters, GLUT1 and 
GLUT4, into cardiac cell membranes. Expression of GLUT4 is known to be 
reduced in individuals with diabetes (69). Hyperglycemia persists and ATP 
production is decreased due to the lack of glucose uptake by cardiac cells in 
these individuals (69). The fact that  
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fatty acids remain the primary source of ATP generation by cardiac myocytes 
also allows for mitochondrial dysfunction to be recognized in diabetic 
cardiomyopathy as an abnormal buildup of lipids is characteristic of this condition 
(22), (25). Evidently, mitochondria remain a crucial organelle for normal cardiac 
function taking into consideration the energetic demands of this organ. 
Pathological conditions which lead to mitochondrial dysfunction and alterations in 
morphology can alter the normal heart function. 
 
Reactive Oxygen Species and Related Pathologies 
     For mitochondria to meet energetic demands, a steady supply of oxygen is 
necessary to accept electrons at the termination of the electron transport chain. 
Mitochondrial oxygen consumption under non-pathological conditions results in 
the production of reactive oxygen species (ROS) which, if neutralized, remain 
unproblematic. However, mitochondrial dysfunction and subsequent ROS 
generation have been linked to obesity and insulin resistance (6), (44). 
Uncoupling protein 1 (UCP1) uncouples ATP synthesis from the proton gradient 
generated during oxidative phosphorylation to facilitate the clearance of ROS (6). 
UCP1 is located in the inner mitochondrial membrane and mitochondrial 
membrane disruption may eliminate its activity in ROS disposal. Moreover, the 
balance between generation and removal of ROS through mitochondrial 
uncoupling can be disturbed in the event of excessive nutrient consumption and  
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overabundant substrate availability for ATP generation through mitochondria (6), 
(44). Consequently, oxidative damage and cell death can occur (6). Excessive 
nutrient availability for prolonged periods of time can also lead to insulin 
resistance (6), (44). The essential activities of mitochondria are also 
accompanied by the generation of destructive by-products; however, 
mitochondrial mechanisms exist to control the damaging effects. Chronic 
pathological conditions may abolish these mechanisms and lead to cellular 
damage and death.  
Aldehyde Dehydrogenase 2 Deficiency 
     Aldehyde dehydrogenase 2 (ALDH2) is a mitochondrial enzyme which exists 
in the matrix and acts during the rate-limiting step of ethanol metabolism to 
convert acetaldehyde to acetic acid (11). Due to the hydrophilic nature of 
acetaldehyde, accumulation of this compound from defects in ALDH2 causes 
adverse reactions in the cell following passage through the lipid bilayers (11), 
(19), (2). Consequently, ALDH2 participates in defense against damage from 
oxidative stress. For example, ALDH2 has a crucial function in neutralizing the 
highly reactive aldehyde products of lipid peroxidation, 4-hydroxynonenal (4-
HNE) and malondialdehyde (MDA) (11), (19), (2). Deficiency in mitochondrial 
aldehyde dehydrogenase has also been linked to several pathologies. Neuron 
cell death and reduced cognitive ability have been presented as the results of 
reactive aldehyde accumulation in the brain (36). Particularly, 4-HNE has been 
implicated in Alzheimer’s disease (36). It has been suggested that ALDH2, which  
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acts to convert the reactive products of lipid peroxidation to less injurious 
compounds, plays a key role in neuroprotection (19). Indeed, upregulation of 
ALDH2 may be considered a marker of improved cognitive function in animal 
models of Alzheimer’s disease (36). Further, D’Souza et al. have shown cognitive 
deterioration in an age-dependent manner in a murine ALDH2 knockout model 
(19). ALDH2 is also present in greater quantities in highly metabolic organs 
which require plenty of oxidative phosphorylation, such as the heart and brain 
indicating the need for protection from oxidative damage (11). Clearly, proper 
mitochondrial function is necessary beyond the energetic demands for ATP 
generation. Enzymes contained in these organelles provide a vital defensive 
function as evidence shows that deleterious effects result from deficits in 
mitochondrial aldehyde dehydrogenase activity.   
 
Apoptosis and the Role of Mitochondria  
     Apoptosis is a form of cellular death which follows a specific and genetically 
controlled procedure. The systematic activation of various proteins results in 
destruction of the cell which can be recognized by characteristic changes in cell 
morphology as well as protein expression. Two forms of apoptosis exist: the 
intrinsic and extrinsic pathways. The extrinsic path of apoptosis requires the 
activation of death receptors at the surface of cells (23).  
     
7 
 
 
     Mitochondria serve as the conduit through which the stress-induced intrinsic 
pathway of apoptosis is carried out. Bak and Bax, pro-apoptotic members of the 
Bcl-2 protein family, are inserted into the mitochondrial membrane to form the 
mitochondrial permeability transition pore (64). Due to this disruption in the 
mitochondrial membrane, cytochrome C is subsequently released from the 
intermembrane space into the cytoplasm. Oligomerization of typically monomeric 
apoptotic protease activating factor-1 (Apaf-1) occurs following hydrolysis of 
dATP to dADP (54). Apaf-1 functions to bind released cytochrome C in the 
cytoplasm to form the apoptosome. This structure, composed of seven Apaf-1 
units and cytochrome C function to cleave procaspase-9 into its active form, 
caspase-9. Activated caspase-9 proceeds to activate caspase-3 through 
cleavage from the inactive procaspase-3 to result in destruction of the cell (54). 
Degradation of the cell involves various processes such as DNA fragmentation, 
shrinkage of the cell and protrusion of the plasma membrane. These 
morphological changes are characteristic indicators of a cell undergoing 
apoptosis through the mitochondrial-mediated pathway. 
 
Mitochondrial Outer Membrane Permeabilization  
     Bax and Bak are Bcl-2 (B-cell lymphoma protein-2) family members and form 
pores in the mitochondrial outer membrane in response to an apoptotic stimulus 
through the intrinsic pathway (21), (72), (38). Homo-oligomerization occurs once  
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Bax and Bak are activated and the BH3 (Bcl-2 homology) domain of one 
molecule will interact with the hydrophobic groove of another activated molecule 
(21). Bax, in monomeric form, primarily remains in the cytosol prior to the 
apoptotic signal after which Bax translocates to the outer mitochondrial 
membrane (OMM) to insert its transmembrane domain (21), (72). This contrasts 
with Bak which perpetually remains anchored to the OMM. Bax and Bak 
regulation mechanisms are unclear, however it is believed that these proteins are 
detained in the cytosol by pro-survival proteins prior to their activation by an 
apoptotic stimulus (21). 
     Voltage-dependent anion channels (VDACs) are considered the most 
predominant outer mitochondrial membrane proteins responsible for ion and 
metabolite flux ranging from 1.5-5 kDa in size (3), (43). Adenine nucleotide 
translocase (ANT), a prevalent inner mitochondrial membrane protein, functions 
in ADP import into the matrix and ATP export eventually to the cytosol (40). The 
OMM pore has been previously thought to include VDACs and ANT (21), (3). 
Evidence is lacking and inconsistent for a necessary role of VDACs in 
mitochondrial permeability pore formation and function during apoptosis (3), (43). 
Although, a regulatory role for ANT has been implicated with proposed pro- and 
anti-apoptotic isoforms (3), (40), (8). Ultimately, the pores created in the 
mitochondrial membrane are primarily established by Bcl-2 proteins and function 
to release cytochrome C into the cytosol from the intermembrane space. 
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Cytochrome C and the Apoptosome 
     Cytochrome C in healthy cells is a key component of the electron transport 
chain and participates in substantial amounts of ATP generation. Yet, the 
resulting mitochondrial dysfunction, apoptosome formation and caspase cascade 
activation from cytochrome C release commits the cell to death (21), (72). 
Cardiolipin (CL), an inner mitochondrial membrane (IMM) lipid, is known to 
anchor cytochrome C to the IMM (38), (65). Accordingly, CL oxidation is thought 
to lead to the release of cytochrome C from the IMM so that it may be 
transported from the intermembrane space into the cytosol (38), (65), (73). 
Further, data from Zhong et al. proposes that modulation of CL oxidation is a 
mechanism used by cancer cells to evade apoptosis (73). Experimental evidence 
by Zhang et al. also suggests that cytochrome C release into the cytosol requires 
contact with Bax, interactions with the pore residues and can influence the pore 
structure to facilitate release (72). Evidently, this systematic process of cell death 
is controlled at multiple levels.  
     Constitutive, but low levels of Apaf-1 are present in cells, however, expression 
can be increased by transcription factors E2F transcription factor 1 (E2F1) and 
tumor-suppressor protein (p53) (54), (33). E2F1 phosphorylation, stabilization, 
subsequent activation of APAF1 genes and apoptosis are known to occur 
following DNA damage or serum starvation (33). The nucleotide-binding 
oligomerization domain (NOD) of Apaf-1 facilitates binding between multiple units 
of Apaf-1 to form the heptameric apoptosome structure (54), (65). The WD40  
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(tryptophan-aspartate) repeats domain (WRD) possesses a regulatory function 
as the binding of cytochrome C to this domain causes a conformational change 
that allows procaspase-9 attachment (54), (65). Multiple Apaf-1 isoforms exist 
ranging from 133-142 kDa with caspase recruitment domains (CARDs) located at 
their N-terminus responsible for binding procaspase-9 (54). It is known that 
dATP/ATP is necessary for Apaf-1 oligomerization, however, cytochrome C 
binding is not dependent on the presence of dATP/ATP (54), (65). The 
apoptosome provides the scaffold which permits the cleavage of procaspase-9 to 
active caspase-9 (54), (65). 
 
 
The Caspase Cascade and Cell Death 
     Caspases are cysteine-aspartic acid proteases which mainly cleave at the C-
terminal end of aspartate residues (30). In particular, caspase-3 and caspase-7 
are further classified as apoptotic effector caspases (30). Procaspases are the 
inactive zymogen forms of caspases which are present in cells prior to cleavage 
to active forms (30). Certain procaspases are expressed as monomers and later 
form dimers after activation, or as dimers which require cleavage within the linker 
region, nevertheless, active caspases ultimately function as dimers (30). 
Apoptosis due to caspases is not limited to the intrinsic pathway as the extrinsic 
pathway of cell death is also carried out by caspase-8, caspase-3 and caspase-7  
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(30). Further, caspases can cause cell death through mechanisms other than 
apoptosis. For example, the binding of LPS to inflammatory caspase-4 and 
caspase-11, in response to bacterial infections, can result in activation, 
oligomerization and inflammatory cell death (30). 
     Once bound to the apoptosome, procaspase-9 cleaves itself in order to 
activate procaspase-3 and procaspase-7 (54), (9). It has been proposed that up 
to four molecules of procaspase-9 attach to the apoptosome (54). Bretnall et al. 
have proposed distinct roles for caspase-9, caspase-3 and caspase-7 in the 
intrinsic apoptosis pathway (9). The data implies additional functions for caspase-
9 such as mitochondrial remodeling (9). Also, caspase-3 may inhibit the 
production of reactive oxygen species as well as being the primary effector 
caspase and caspase-7 may be responsible for cleavage of ECM proteins and 
cell detachment (9). Nevertheless, the resulting effects of the caspase cascade 
on the cell include shrinkage of the cell, DNA fragmentation, membrane blebbing 
and exposure of phosphatidylserines to the extracellular environment (30), (9). 
This controlled process of cell death ensures un-injurious degradation and 
removal of damaged or unwanted cells. 
 
Oxygen Free Radicals and Apoptosis 
     Oxygen free radicals exist as types of highly reactive oxygen-containing 
molecules due to the possession of an unpaired electron. Similarly, reactive  
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oxygen species (ROS) exist as a class of highly reactive oxygen-containing 
compounds with roles in multiple cellular functions including cell death and can 
include superoxide (O2-) and hydrogen peroxide (H2O2) (47). Routine cellular 
activities, such as aerobic respiration, can result in the production of ROS. 
Further, nitric oxide synthase (NOS) can contribute as an endogenous source of 
ROS under conditions of reduced availability of tetrahydrobiopterin or L-arginine 
and ultimately generates OH• and NO2• (47), (4). Hypoxic conditions additionally 
serve as a cause of mitochondrial production of ROS (47). ROS maintain the 
ability to both stimulate and inhibit cell death (47), (4). 
 
Aerobic Respiration and ROS Production 
     Mitochondria house an electron transport chain (ETC) which coincides with its 
purpose of serving as the major source of energy for cells. Remarkably, it is the 
ETC which also provides the major source of ROS in mammalian cells (4), (51). 
Electron “leak” in pairs from electron carriers forms H2O2 and a single electron 
leak forms superoxide (60).  Complex III (cytochrome C oxidoreductase) and 
complex IV (cytochrome C oxidase) are the sites of superoxide production in the 
ETC (51), (60). Although mitochondrial respiration is the major source of ROS, 
the amount produced is not sufficient to cause devastating effects on the cell in 
non-disease states.  
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Hypoxia and ROS Production via Mitochondria 
     Mitochondrial production of ROS functions in normal cell signaling when 
generated at low concentrations (27). However, a deficiency in oxygen available 
to cells is suggested to result in mitochondrial ROS production by complexes I 
and III (27), (59), (74). Superoxide appears to be the primary ROS generated by 
complex III under hypoxic conditions and ROS from complex III are thought to 
activate hypoxia-inducible factor-1α (HIF-1α) (27), (74). HIF-1 plays a protective 
role for cells experiencing hypoxic conditions and is known to execute a number 
of functions in response to low oxygen levels in attempts to maintain cell survival 
(10). However, Shvetsova et al. have provided evidence which shows that HIF-
1α activation is dependent on the proper functioning of mitochondria (74).   
 
ROS and Apoptosis 
     Production of ROS, if not equally countered by their catabolism, can result in 
accumulation which leads to oxidative stress (47). This excessive quantity of 
ROS can react with biomolecules to cause cellular and DNA damage resulting in 
cell death. Evidence exists to support the role of hydrogen peroxide (H2O2) 
contributing to oxidative stress and ultimately signaling apoptosis through the 
intrinsic pathway (51), (39). Liu et al. have shown that H2O2 can induce cellular 
morphological defects, oxidative stress, increased levels of Bax, disruption of 
ΔΨm and apoptosis (39). Additionally, Bcl-2 is known to be involved in inhibition  
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of cell death through apoptosis (7). Kern et al. have provided evidence for the 
role of Bcl-2 in prevention of endothelial superoxide (O2-) production in a murine 
model of Bcl-2 overexpression (32). Further, support exists for a reduction in 
apoptosis in a model of mitochondrial superoxide dismutase (SOD2) expression 
by adenovirus transfection (7). Together, the present evidence suggests that 
oxidative stress, attributable to H2O2 and O2-, bring about apoptosis through the 
mitochondrial-mediated pathway. 
     Mechanisms do exist to regulate the production of ROS. For example, the 
availability of necessary cofactors, receptor activation and cell signaling 
cascades which result in ROS production can be controlled (47). Furthermore, 
enzymes exist to neutralize harmful oxygen free radicals. Superoxide dismutase 
(SOD) functions to convert O2- into H2O2 which can be further broken down into 
water and oxygen by the enzyme catalase. Mn-dependent SOD (SOD2) exists in 
the mitochondrial matrix and functions to protect mitochondria from the effects of 
O2-. However, few researchers have observed SOD2 decrease in response to 
oxidative stress induced by H2O2  (39). 
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Nitric Oxide (NO) and Apoptosis 
Infection and the Immune Response  
     Invasion by foreign microbes or toxins elicit standard responses by the 
immune system which are categorized as innate and adaptive. Adaptive 
immunity includes specific T-cell and B-cell responses which require more time to 
occur and last for longer periods compared to innate immune responses (48). 
Innate immunity involves an initial swift response to invading pathogens and 
toxins due to recognition of foreign molecular structures (48). Release of 
inflammatory mediators is a well-established innate immune reaction (48), (50).  
Macrophages, derived from monocyte differentiation, function in the innate 
immune response to eliminate invading microbes through nitric oxide (NO) 
release and oxidative damage (48). Apoptosis can occur because of infection by 
many bacterial species despite efforts by the immune system to control and 
eliminate pathogens (50). Bacterial toxins, such as lipopolysaccharide (LPS) 
derived from gram negative species, are also known elicit inflammation due to its 
recognition by Toll-like receptor 4 (TLR4) (12). Pro-inflammatory factors, such as 
tumor necrosis factor alpha (TNF-α), interferon-gamma (IFN-γ), interleukin-6 (IL-
6) and LPS can lead to the generation of NO by inducible nitric oxide synthase 
(iNOS) (61). Macrophage release of NO in response to LPS has been well-
characterized as well as the cytotoxicity of high exogenous NO levels (46), (62). 
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Role of NO in the induction of apoptosis 
     There exist three enzymatic sources of NO production by nitric oxide 
synthases including neuronal (nNOS), endothelial (eNOS) and inducible (iNOS) 
(61), (62). NO production by nNOS and eNOS from L-arginine remains a 
physiological necessity, however, iNOS production of NO is known to occur 
under inflammatory conditions (61), (62). In addition to its role in maintaining 
normal physiological functions, NO is involved in inducing mitochondria-mediated 
cell death (13). Snyder et al. has provided experimental data implicating that NO 
induces the formation and subsequent insertion of Bax/Bak oligomers into the 
outer mitochondrial membrane to result in cytochrome C release and apoptosis 
(61).  
 
Endotoxemia or Sepsis and Apoptosis  
Sepsis and Apoptosis 
     Sepsis occurs as the result of a widespread inflammatory reaction to infection. 
This condition consists of two stages: hyperdynamic and hypodynamic, also 
referred to as the warm and cold stages of sepsis, respectively. The initial 
hyperdynamic stage involves warm and perfused extremities due to high cardiac 
output and low peripheral resistance of blood vessels. However, the 
cardiovascular system is unable to maintain this perfused stage which can lead 
to a decline to the hypodynamic stage (15), (55). When this occurs, organ  
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perfusion is dramatically reduced. A patient in this stage of sepsis will experience 
cold extremities due to the effects of inflammation on vascular permeability and 
subsequent lack of perfusion.  
     Data from Chopra et al. has provided evidence to show that adult rat 
ventricular myocytes (ARVMs) undergo apoptosis (14). The evidence implicates 
the involvement of the intrinsic pathway of apoptosis due to the increased levels 
of Bax and cytochrome C as well as morphological changes in mitochondria such 
as swelling and membrane deformity (46),(68). Further, progression to apoptosis 
in sepsis has been well-documented in the pathophysiology of sepsis (13), (67).  
 
Endotoxemia and Apoptosis 
     Endotoxemia is defined as the presence of endotoxins in the blood, for 
example, lipopolysaccharide (LPS) derived from the outer membranes of gram-
negative bacteria. Consequences of endotoxemia include metabolic endotoxemia 
defined as endotoxins in the blood derived from intestinal bacteria, the 
development of inflammation, shock, or death (37), (20). The induction of 
endotoxemia under experimental conditions can be utilized as a model system 
for studying pharmacological interventions for septic patients (31). According to 
Kamisoglu et al., the pathophysiology of sepsis and endotoxemia share similar 
metabolic profiles and the metabolic distinctions between endotoxemia and 
sepsis increase with time (31). These findings suggest that pharmacological  
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treatments evaluated during experimental endotoxemia should be administered 
as early as possible during the onset and progression of sepsis in patients.  
      Present data also provides evidence for the ability of LPS to induce apoptosis 
in hepatocytes at 1000 ng/mL (49). In addition to cell death, LPS has been 
observed to produce dissipated ΔΨm, reduced levels of ATP and mitochondrial 
cytochrome C (49). Moreover, Wang et al. have demonstrated the capacity for 
LPS to induce apoptosis and caspase-3 activity in adult rat ventricular myocyte 
(ARVM) at concentrations as low as 10 ng/mL (66). Further, this study also 
demonstrated a greatly enhanced effect of LPS on disrupted ΔΨm, mitochondrial 
Bax translocation and cytochrome C release in combination with β1-adrenergic 
receptor activation in cardiomyocytes (66). Together, these experimental data 
support the capacity for LPS-induced endotoxemia to cause mitochondrial 
dysfunction and activation of the intrinsic apoptosis cascade - effects which can 
be augmented by β-adrenergic stimulation and affect multiple cell types. 
However, the degree of these effects appears to vary with LPS concentration. 
 
MitoKATP Channels and Apoptosis  
     Potassium ATP (KATP) channel structure consists of 4 subunits each of Kir and 
SUR proteins. The aqueous pore through which potassium ions flow out of the 
cell is formed by the Kir subunits. The SUR subunits exhibit pharmacological 
functions in that they contain binding sites for various agents which affect ion flow  
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through the channel. Ion transport through these channels can be regulated by 
varying ATP and nucleotide diphosphate concentrations. During the physiological 
state, mitoKATP channels function to transport potassium ions into the matrix to 
maintain volume. Low levels of ATP can activate the flow of potassium ions 
through these channels and increased flow of potassium out of the cell leads to 
hyperpolarization of the cell membrane. In mitochondria, the opening of these 
channels leads to depolarization of the mitochondrial membrane (68).  
Matrix Volume and Cytochrome C Release 
     Mitochondrial swelling due to increased matrix volume has been shown to 
result in cytochrome C release without the need for increased mitochondrial 
membrane permeability (28). Evidence also exists to suggest that mitochondrial 
swelling due to K+ influx through mitoKATP channels can rupture the OMM and 
permit cytochrome C release (18). Moreover, recent data has shown that 
valinomycin, an ionophore specific to K+, can induce mitochondrial swelling and 
release of cytochrome C (41). Consequently, blockage of mitoKATP channels by 
5HD, a mitoKATP channel blocker, may reduce matrix swelling and cytochrome C 
release, thereby reducing the extent of cell death under the intrinsic pathway of 
apoptosis.  
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MitoKATP Channels and Mitochondrial Membrane Potential (ΔΨm)  
     Dissipation of mitochondrial membrane potential (ΔΨm) has been considered 
an early event in apoptosis and also necessary for cytochrome C release (63). 
Likewise, collapse of ΔΨm is linked to the progression of cell death and is a 
conventional parameter used for detection and measurement of apoptosis (63). 
Reduced mitochondrial membrane potential is a known result of mitoKATP 
channel opening (42). Accordingly, prevention of mitoKATP channel activity may 
limit the degree of ΔΨm disruption and reduce the magnitude of cell death.  
 
Reactive Oxygen Species 
     MitoKATP channel opening has been found to lead to increases in 
mitochondrial generation of ROS, particularly superoxide and hydrogen peroxide 
(18), (42), (70). This effect has also been proposed as a mechanism of 
cardioprotection from prolonged ischemic damage through ROS signaling 
pathways - an effect which can be induced by the mitoKATP channel opener 
diazoxide and inhibited by 5-HD (18), (70). However, the effects of ROS signaling 
are concentration-dependent and oxidative stress is known to cause cell death 
involving the intrinsic apoptosis pathway (17). Consequently, it can be suggested 
that under the conditions of sepsis or endotoxemia, mitoKATP channel opening 
may be detrimental to the survival of patients experiencing myocardial  
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dysfunction. Rather, blockage of these channels may prove more beneficial to 
the condition as a method of preserving cardiomyocyte function.  
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AIMS AND OBJECTIVES 
     Vascular dysfunction, end-organ failure and high mortality rates are 
associated with endotoxemia, sepsis and septic shock. Recently, focus has been 
on mitochondrial ultrastructural changes and function due to sepsis and sepsis-
related pathologies. Data from Sharma’s laboratory indicated involvement of 
mitochondrial-mediated intrinsic apoptosis cascade in regulating ARVM 
dysfunction in sepsis. Experimental endotoxemia has shown mitochondrial 
membrane potential collapse, membrane permeability changes and release of 
cytochrome C as indicators of mitochondrial dysfunction. Outer mitochondrial 
membrane (OMM) permeability is controlled by Bax translocation, resulting 
Voltage Dependent Anion Channels (VDACs) pores in the OMM and activation of 
mitoKATP channels in the inner mitochondrial membrane. Endotoxins can induce 
mitochondrial damage and there is a correlation between the severity of sepsis 
and mitochondrial damage and dysfunction. The data from our laboratory 
indicate that 5HD treatment that blocks mitoKATP channels could increase 
survival in septic rats and increase contractility in septic cardiomyocytes. He 
progression of sepsis is known to involve vascular dysfunction. Therefore, we 
hypothesize that inhibition of mitoKATP channels by 5HD restores altered 
mitochondrial membrane permeability in human umbilical vein endothelial cells 
due to LPS-induced endotoxemia. To investigate this hypothesis the following 
specific aims are developed.  
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Specific Aim 1. To determine time-dependent and dose-dependent effects 
of LPS and 5HD on mitochondrial dysfunction in HUVECs 
     Prior to testing the restorative properties of 5HD (5-hydroxydecanoic acid) on 
mitochondrial membranes in endotoxic human umbilical vein endothelial cells 
(HUVEC), it is necessary to determine the time- and dose-dependent effects of 
5HD and lipopolysaccharide (LPS) on HUVEC viability. Cell viability assays have 
been conducted using Presto blue dye to measure metabolic activity of the cells 
following treatment with LPS and 5HD at increasing concentrations.   
 
Specific Aim 2. To determine if 5HD modulates LPS-induced a) 
mitochondrial dysfunction b) NO and catalase levels and c) proapoptotic 
markers such as Bax, Cytochrome C and Apaf-1 in HUVECs 
     The effect of 5HD on LPS-induced alterations of mitochondrial membrane 
potential (measure of mitochondrial membrane integrity) in HUVECs can be 
determined. Macrophages serve as a positive control as the ability of LPS to 
decrease viability of these cells has been well characterized. Mitochondrial 
membrane potential will be assessed using JC-1 cationic dye. NO and catalase 
levels were measured by colorimetric assay and levels of proapoptotic proteins 
were measured using immunoblot procedures. 
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Materials and Methods 
Chemical Preparations 
     Chemical compounds were purchased from Sigma-Aldrich (St. Louis, MO) 
and prepared in sterile deionized water. Treatments were prepared in warm 
Medium 200 (GibcoTM; Thermo Fisher Scientific, Grand Island, NY) at the 
required concentrations. All drugs and treatments were prepared under sterile 
conditions and vortexed prior to usage.  
5-Hydroxydecanoic Acid (5HD) 
     5-hydroxydecanoic acid sodium salt (MW; 210.25 g/mol) was prepared at a 
100,000 μM stock concentration. The 100,000 μM stock was further diluted to a 
working concentration of 1000 μM in sterile deionized water. 1000 μM 
concentration aliquots were prepared and stored at -80oC for future use.  
Lipopolysaccharide (LPS) 
     Lipopolysaccharide was prepared at a 100,000 ng/mL stock concentration. 
The 100,000 ng/mL stock was further serially diluted to 10,000 ng/mL and then to 
a working concentration of 1000 ng/mL in sterile deionized water. 1000 ng/mL 
concentration aliquots were prepared and stored at -80oC for future use.  
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Cell Culture 
     Human umbilical vein endothelial cells (HUVEC) were purchased from ATCC 
(Manassas, VA) and cultured in Medium 200 supplemented with low serum 
growth supplement (LSGS) (GibcoTM; Thermo Fisher Scientific, Grand Island, 
NY) containing 10 µg/mL heparin, 1 µg/mL hydrocortisone, 10 ng/mL human 
epidermal growth factor, 3 ng/mL basic fibroblast growth factor, 2% FBS and 1% 
penicillin and streptomycin (46). Cells were incubated at 37oC, 5% CO2 and 80% 
humidity. Medium was exchanged every other day and cells were passaged at 
95% confluency in trypsin plus 0.25% EDTA. Cells were cultured and maintained 
in T175 cell culture flasks and treated at 75-80% confluency for cytotoxicity 
assays and 90-95% confluency for all other assays.  
Treatment 
     Cells were passaged with trypsin plus 0.25% EDTA, counted using the trypan 
blue cell counting method and cell suspension was plated on cell culture plates at 
volumes and seeding densities based on specifications necessary for each 
experiment. Treatments were prepared based on cell culture plate well volume 
and concentration of drug required per well from 1000 μM or 1000 ng/mL working 
concentrations. A master mix was prepared and calculated for based on the 
number of plated wells to be treated and the volume of each well. All drugs were 
prepared in Medium 200 warmed in a 37oC water bath and under sterile 
conditions, vortexed and mixed during treatment preparation as well as prior to  
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addition to cells. HUVEC model of endotoxemia was induced by treatment of 
cells with LPS 100 ng/mL.  
Determination of Cell Viability 
     HUVECs were cultured on 48-well plates and seeded at a density of 70,000 
cells per well. The cells were treated with LPS for 16 and 24 hours with the 
following dosages: 50 ng/mL, 100 ng/mL, 500 ng/mL, 1000 ng/mL, 5000 ng/mL 
and LPS 100 ng/mL plus 5HD 50 µM. Cells were treated with 5HD at the 
following dosages: 50 µM, 100 µM, 200 µM and 500 µM. Cells were treated at 
75-80% confluency. Cells were incubated for 1 hour with PrestoblueTM Cell 
Viability Reagent (Molecular Probes; Invitrogen, Carlsbad, CA) and absorbance 
was measured using Biotek Synergy HT microplate reader. Cell viability was 
quantified based on absorbance of metabolically active cells at 570 nM. 
 
Determination of Mitochondrial Membrane Potential  
JC-1 Fluorescent Imaging (13) 
     JC-1 assay kit was purchased from Molecular Probes (Life Technologies; 
Thermo Fisher, Grand Island, NY). Performance of the JC-1 cationic dye assay 
was adapted from vendor directions. HUVECs were cultured and plated on 48-
well plates at 60,000 cells per well and treated at 90% confluency with the 
following treatment groups: LPS 100 ng/mL, 5HD 50 µM and LPS plus 5HD.  
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Assays were performed at 2, 4, 6, 16 and 24 hours. Carbonyl cyanide 3-
chlorophenylhydrazone (CCCP), a mitochondrial membrane depolarizer, was 
added 5 minutes prior to addition of JC-1 dye at a final concentration of 50 μM as 
per vendor guidelines to serve as a positive control for JC-1 fluorescence activity. 
Treatment groups and positive controls were incubated with 5 µL of 200 µM JC-1 
cationic dye for 30 minutes and washed with 10X PBS. Cells were imaged using 
EVOS FL Cell Imaging System (Thermo Fisher Scientific, Grand Island, NY) at 
20X magnification. 
 
Immunoblot Analysis (13) 
     HUVECs were seeded at a density of 2x106 cells per well on 6-well cell 
culture plates and treated with LPS 100 ng/mL, 5HD 50 μM and LPS plus 5HD 
for 16 hours. Cells were lysed with 100 μL RIPA buffer and incubated on ice for 5 
minutes. The collected lysate remained on ice for 10 minutes prior to 
centrifugation at 13.3g and 4oC for 10 minutes. Protein quantification of collected 
lysate was performed using PierceTM BCA Protein Assay Kit (Thermo Fisher, 
USA) according to vendor directions. 40 μg of protein sample was loaded into 
each sample well of gel. Gels were run at 150V for 1 hour prior to transfer to 
PVDF membrane. Membranes were incubated with primary antibody overnight at 
4oC on a rocker and secondary antibody for 45 minutes at room temperature on a 
rocker. Primary antibody was prepared in 5 mL Odyssey® Blocking Buffer (PBS)  
28 
 
 
(Li-COR, USA), 5 μL Tween 20 and 1 μL mouse monoclonal β-actin antibody 
(Santa Cruz). All primary antibodies were prepared at a 1:1000 concentration. 
Membranes were imaged using Li-COR Odyssey® CLx Imaging System 
(Lincoln, NE) for 7 minutes exposure time per membrane. Bands were quantified 
using Li-COR Image StudioTM Lite (Lincoln, NE). All samples were run in triplicate 
(N = 3).  
Apoptotic Protease Activating Factor 1 (Apaf1) 
     Samples were run on 10-well 7.5% SDS gels prepared according to directions 
adapted from Northern Arizona University Lab Protocols. Rabbit polyclonal anti-
Apaf1 antibody was purchased from Abcam (Cambridge, MA). PVDF 
membranes were incubated with 1 μL anti-rabbit and 1 μL anti-mouse secondary 
antibodies. 
Cytochrome C and Bax 
     Samples were run on 10-well 4-20% gels purchased from Bio-Rad (Hercules, 
CA). Sheep polyclonal anti-Cytochrome C and rabbit monoclonal anti-Bax 
antibodies were purchased from Abcam (Cambridge, MA). PVDF membranes for 
Bax quantification was incubated with 1 μL anti-mouse plus 1 μL anti-rabbit. 
PVDF membranes for Cytochrome C quantification were incubated with 1 μL 
anti-sheep purchased from Abcam (Cambridge, MA) and 1 μL anti-mouse 
secondary antibodies.  
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Assays 
Enzyme-Linked Immunosorbent Assays 
Catalase  
     HUVECs were seeded at a density of 2x106 cells per well on 6-well cell 
culture plates and treated with LPS 100 ng/mL, 5HD 50 μM and LPS plus 5HD 
for 16 hours. Following treatment, cells were lysed and protein was extracted for 
catalase quantification using Abcam Human Catalase ELISA Kit (Cambridge, 
MA) adapted from manufacturer directions. HUVEC lysate was centrifuged at 
13.3 g for 20 minutes at 4oC and the collected supernatant was immediately 
assayed. Samples were incubated with capture and detection antibody cocktail 
out of direct light and at room temperature for 1 hour and 15 minutes on a plate 
shaker at 150 rpm. Optical density (OD) was recorded at 450 nM using Biotek 
Synergy HT microplate reader. Samples were assayed as three sets for each 
treatment group and run in duplicates (N = 6).  
Griess Reagent Assay (56) 
     HUVECs supernatant was collected from prior treatments with LPS 100 
ng/mL, 5HD 50 μM and LPS plus 5HD for 2, 4, 6, 16 and 24 hours and used for 
quantification of nitrite release using Promega Griess Reagent System (Madison, 
WI). Samples were run in three sets in duplicates (N = 6) on a 96-well plate 
according to manufacturer protocol. Samples were incubated for 10 minutes at 
room temperature and out of direct light with sulfanilamide. Samples were then  
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incubated for 10 minutes at room temperature and out of direct light with N-1-
napthylethylenediamine dihydrochloride (NED). Absorbance was measured at 
520 nM using Biotek Synergy HT microplate reader. 
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Results 
Effect of LPS (50, 100 and 1000 ng/mL) on HUVEC viability   
The effect of LPS at increasing concentrations, i.e., 50, 100 and 1000 
ng/mL was observed in HUVEC. With increasing concentration, a decrease in 
HUVEC viability was observed in cells treated with LPS 50 ng/mL, 100 ng/mL 
and 1000 ng/mL for both 16 (Fig. 1) and 24 (Fig. 2) hours. This suggests that 
LPS deceases cell viability in dose-dependent and time-dependent manner. 
Effect of 5HD on HUVEC viability 
5HD, a putative mitoKATP blocker, produces a decrease in viability in 
HUVEC treated with 5HD 50 μM, 100 μM and 200 μM for 24 hours. Significant 
reductions in HUVEC viability were observed at the aforementioned 
concentrations with the higher concentrations of 100 and 200 μM producing 
similar significant reductions in cell viability. This data suggests that 5HD reduces 
HUVEC viability at increasing concentrations of the compound (Fig. 3). 
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Figure 2: Dose-dependent effect of LPS (50, 100 and 1000 ng/mL) on human umbilical 
vein endothelial cell (HUVEC) viability at 24 hours. The dose-dependent effects of LPS 50 
ng/mL and LPS 100 ng/mL on HUVEC viability at 24 hours. 
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Figure 1: Dose-dependent effect of LPS (50, 100 and 1000 ng/mL) on human umbilical 
vein endothelial cell (HUVEC) viability at 16 hours. The dose-dependent effects of LPS 50 
ng/mL and 100 ng/mL on HUVEC viability at 16 hours.  
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Figure 3: Dose-dependent effect of 5-hydroxydecanoic acid (5HD) on human umbilical 
vein endothelial cell (HUVEC) viability at 24 hours. The dose-dependent effects of 5HD at 
50 μM, 100 μM and 200 μM on HUVEC viability at 24 hours. Statistical significance was 
determined through one-way analysis of variance (ANOVA). P < 0.0001 
*** 
*** *** 
*** 
*** *** 
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Effect of 5HD on LPS-induced effect on nitrite levels  
The time-dependent effect of 5HD on LPS-induced effects on nitrite 
release was measured in HUVEC treated at 2, 4, 6, 16 and 24 hours. HUVEC 
treated with LPS alone showed significant increases in nitrite release following 
treatment for 16 and 24 hours. 5HD (50 μM) in the presence of LPS at 100 ng/mL 
did not affect the LPS-induced elevated levels of nitrite at both 16 and 24-hour. 
This suggests that 5HD does not diminish the LPS-induced nitrite release in 
HUVEC (Fig. 4). 
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Figure 4. Effects of LPS, 5HD and LPS + 5HD on nitrite release in HUVEC. The effects of 
LPS 100 ng/mL, 5HD 50 μM, and LPS + 5HD nitrite release in HUVECs treated for 2, 4, 6, 16 
and 24 hours. Statistical significance was determined through one-way analysis of variance 
(ANOVA). P < 0.0001 
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The Effect of 5HD on LPS-induced effect on cytosolic Bax, Cytochrome C 
and Apaf-1 proteins  
The effect of 5HD (50 µM) in the presence and absence of LPS (100 
ng/mL) was observed using Western blot at 16 hours post treatment. LPS did not 
significantly alter protein levels of cytosolic Bax and Cytochrome C. Also, 5HD 
did not alter the effect of LPS on Bax and Cytochrome C levels (Fig. 5 and Fig 6, 
respectively).  
 LPS produces a significant decrease in the levels of Apaf-1 (Fig. 7). 
Treatment with 5HD significantly reduced levels of Apaf-1 compared to control 
(alone group).   
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Figure 5. Effect of 5HD on the LPS-induced response on Bax. Effect of LPS 100 ng/mL, 
5HD 50 μM and LPS + 5HD on the levels of Bax protein in HUVEC treated for 16 hours.  
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Figure 6. Effect of 5HD on the LPS-induced response on Cytochrome C. Effect of LPS 100 
ng/mL, 5HD 50 μM and LPS + 5HD on the levels of Cytochrome C protein in HUVEC treated for 
16 hours. 
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Figure 7. Effect of 5HD on the LPS-induced response on protein levels of Apaf1. Effect of 
LPS 100 ng/mL, 5HD 50 μM and LPS + 5HD on the levels of Apaf1 protein in HUVEC treated 
for 16 hours. Statistical significance was determined through one-way analysis of variance 
(ANOVA). *P < 0.0197, **P < 0.0175, P < 0.0001 
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Effect of 5HD on LPS-induced mitochondrial membrane potential 
alterations in HUVEC  
The effect of 5HD on mitochondrial membrane integrity in LPS-treated 
HUVEC was visualized at 16 and 24 hours by JC-1 assay. Mitochondrial 
membrane disruption is evident as green fluorescence in LPS treatment groups 
at both 16 and 24 hours indicating the presence of cytoplasmic JC-1 monomers 
(Fig. 8 and 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Effect of LPS, 5HD and LPS + 5HD on mitochondrial membrane potential (∆Ψm) in 
HUVEC. The effect of LPS 100 ng/mL, 5HD 50 μM and LPS + 5HD on mitochondrial membrane 
potential in HUVECs treated for 16 hours. 
 
41 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Effect of LPS, 5HD and LPS + 5HD on mitochondrial membrane potential (∆Ψm) in 
HUVEC. The effect of LPS 100 ng/mL, 5HD 50 μM and LPS + 5HD on mitochondrial membrane 
potential in HUVECs treated for 24 hours. 
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The effect of 5HD on LPS-induced increase in cytosolic catalase  
LPS-induced endotoxemia is known to lead to the production of reactive 
oxygen species and ultimately oxidative stress (27). To determine whether 5HD 
plays a role in protection from oxidative damage in endotoxic HUVEC, catalase 
levels were quantified through ELISA following 16-hour treatment. LPS-treated 
HUVEC showed a significant increase in catalase expression. A high level of 
catalase in response to LPS was blocked by co-treatment with 5HD (Fig. 10) 
suggesting that 5HD offers endotoxic cells protection from the generation of 
reactive oxygen species.  
   
Figure 10. Effect of 5HD on LPS-induced increase in Catalase. The effect of 5HD 50 μM on the 
LPS-induced increase in catalase protein expression in HUVECs treated for 16 hours. Statistical 
significance was determined through one-way analysis of variance (ANOVA). P < 0.0001 
 
 
 
43 
 
 
DISCUSSION 
Sepsis, septic shock and endotoxemia have been shown to produce 
vascular perfusion dysfunction in experimental models (1, 52, 53, 57). Likewise, 
in the current in vitro model of endotoxemia in HUVEC, a 25 and 30% decrease 
in cell viability after 16 and 24 hours post LPS treatment was observed. 
Additionally, a 51% decrease after 24-hour treatment with LPS 1000 ng/mL was 
observed suggesting a time- and dose-dependent decrease in cell viability in 
HUVECs. Similar data has been reported by other investigators (46, 58). 
 It is well-established that LPS activates the toll-like receptor 4 (TLR-4) 
signaling pathway (26), (16). The TLR-4 pathway ultimately activates NF-κB 
nuclear translocation which can go on to induce the transcription of pro-
inflammatory molecules and iNOS (26). Choy et al. have recently demonstrated 
that LPS acts through the TLR-4 pathway to induce apoptosis in HUVEC as well 
as increases inducible nitric oxide synthase (iNOS) levels (16). Additionally, 
nitrite can be used to generate nitric oxide (NO) and can, therefore, also be used 
to indirectly quantify levels of NO production (35). Experimental evidence shows 
that LPS treatment increases nitrite levels in HUVEC in a time-dependent 
manner. However, it appears that 5HD does not diminish the LPS-induced nitrite 
release in HUVEC. These data suggest that the protective effects of 5HD likely 
occur downstream of initial inflammatory events in response to LPS.  
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LPS-induced endotoxemia is known to lead to the production of reactive 
oxygen species and ultimately oxidative stress (61). MitoKATP channel opening is 
also known to lead to the production of ROS, an effect which can be opposed by 
blockage of the channel by 5HD (18). Prevention of mitoKATP channel activity by 
5HD could reduce the generation of ROS from mitoKATP channels and therefore 
suppress the need for antioxidant enzyme expression. Data show that LPS 
treatment increases catalase levels. Low levels of ROS are known to be typically 
generated as a result of oxidative phosphorylation which may be involved in the 
catalase levels observed in the control group. 5HD treatment alone resulted in 
catalase levels similar to the control group suggesting that the protective effects 
of 5HD are limited to HUVEC in endotoxemia rather than healthy cells. However, 
treatment of HUVEC with LPS induced an increase in the levels of H2O2 as 
indicated by the greater catalase levels. In contrast, 5HD reduced this LPS-
induced increase in catalase expression. These results suggest that 5HD may 
offer protection to endotoxic cells from oxidative damage by preventing the 
generation of excessive H2O2 thereby reducing the need for catalase activity.   
Since, in the current study, 5HD did not alter LPS-induced elevated NO levels, it 
appears the free radical scavenging effect could by mediated through cytosolic 
catalase and may have no or negligible effects from superoxide dismutase.  
Further studies are needed to establish this stipulation. 
LPS has been shown to induce cell death directly in several in vitro 
models such as bovine endothelial cells and HUVECs (45),(29). Shioiri et al.,  
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(2009) reported that LPS causes activation of caspse-3 and 7, decreases cell 
viability and produces cytotoxicity. In the current study, we observed that LPS 
failed to produce an increase in cytosolic- Bax and cytochrome C levels. This 
result is most likely due to the fact that LPS causes activation of caspse-3 which 
rapidly releases to the supernatant (58). In addition, cytochrome C is released 
from the intermembrane space rather than expressed and Bax exists primarily in 
the cytosol prior to mitochondrial relocation and oligomerization following an 
apoptotic stimulus (21), (72). Moreover, 5HD reduces Apaf-1 expression due to 
LPS-induced endotoxemia in HUVEC. These data suggest that 5HD treatment 
can prevent Apaf-1 expression above normal baseline levels in endotoxic 
HUVEC which may prevent apoptosome formation. However more studies are 
warranted to confirm this speculation.   
To elucidate the role of the intrinsic apoptotic cascade mediated via 
mitochondria, we also studied role of 5HD in mitochondrial membrane potential 
alterations, an indicator for mitochondrial integrity, during endotoxemia in 
HUVECs. Preservation of mitochondrial membrane potential (∆Ψm) requires 
intact mitochondrial membranes. Mitochondrial membrane permeabilization due 
to Bax insertion and pore formation which facilitates cytochrome C release is 
known to occur under the intrinsic pathway (24). Pore formation can impede 
oxidative phosphorlation and the resulting ATP depletion may activate mitoKATP 
channels. MitoKATP channel opening leads to influx of potassium ions, matrix 
swelling and depolarization which are known to occur in apoptosis. The increase  
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in matrix volume due to this channel opening has also been shown to disrupt 
outer mitochondrial membrane integrity and contribute to cytochrome C release 
(28), (18). 5HD appears to alleviate the LPS-induced mitochondrial membrane 
potential alterations in endotoxic HUVEC at both 16 and 24 hours. HUVEC 
treated with 5HD alone for 16 hours exhibited more red than green fluorescence 
compared to 24-hour treatment which shows substantially more green than red. 
This abundance of cytoplasmic JC-1 monomers at 24 hours suggests that 
prolonged exposure to 5HD may disrupt ∆Ψm in healthy HUVEC. Greater red 
fluorescence is noticeable following LPS and 5HD co-treatment which indicates 
more JC-1 aggregates within mitochondria with intact ∆Ψm compared to LPS 
alone at 16 and 24 hours. Considerable green color is not obvious in LPS group 
at 16 hours compared to 24 hours indicating that LPS in a time-dependent 
manner produced the degree of ∆Ψm, an effect which was reversed by inhibition 
of mitoKATP channels. The data supports our earlier obvervation in ARVM, where 
5HD, a mitoKATP channel blocker, increased viability of septic cardomyocytes 
and survival of septic animals (13).  
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CONCLUSIONS 
The current study provides evidence for the role of 5HD, a putative 
mitoKATP blocker, in preserving ∆Ψm in endotoxic cells. 5HD may exert a 
protective effect on endotoxic HUVEC by reducing the magnitude of cell death as 
this compound appears to play a role in preventing Apaf-1 expression and 
maintaining ∆Ψm in endotoxic HUVEC which may reduce cytochrome C release. 
Further protection from cell death arises from the ability of 5HD to reduce H2O2 
generation in endotoxic HUVEC.   
 
 
 
 
 
 
  
48 
 
 
REFERENCES 
1. Alden KJ, Motew SJ, Sharma AC, and Ferguson JL. Effect of 
aminoguanidine on plasma nitric oxide by-products and blood flow during chronic 
peritoneal sepsis. Shock 9: 289-295, 1998. 
2. Anderson EJ, Katunga LA, and Willis MS. Mitochondria as a source 
and target of lipid peroxidation products in healthy and diseased heart. Clin Exp 
Pharmacol Physiol 39: 179-193, 2012. 
3. Baines CP. The molecular composition of the mitochondrial permeability 
transition pore. J Mol Cell Cardiol 46: 850-857, 2009. 
4. Bhattacharyya A, Chattopadhyay R, Mitra S, and Crowe SE. Oxidative 
stress: an essential factor in the pathogenesis of gastrointestinal mucosal 
diseases. Physiol Rev 94: 329-354, 2014. 
5. Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi 
A, Giorgi C, Marchi S, Missiroli S, Poletti F, Wieckowski MR, and Pinton P. 
ATP synthesis and storage. Purinergic Signal 8: 343-357, 2012. 
6. Bournat JC, and Brown CW. Mitochondrial dysfunction in obesity. Curr 
Opin Endocrinol Diabetes Obes 17: 446-452, 2010. 
7. Brand MD. Mitochondrial generation of superoxide and hydrogen 
peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med 
100: 14-31, 2016. 
49 
 
8. Brenner C, Subramaniam K, Pertuiset C, and Pervaiz S. Adenine 
nucleotide translocase family: four isoforms for apoptosis modulation in cancer. 
Oncogene 30: 883-895, 2011. 
9. Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, and 
Boise LH. Caspase-9, caspase-3 and caspase-7 have distinct roles during 
intrinsic apoptosis. BMC Cell Biol 14: 32, 2013. 
10. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol 
125: S3-23, 2010. 
11. Chen CH, Ferreira JC, Gross ER, and Mochly-Rosen D. Targeting 
aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94: 1-34, 
2014. 
12. Chi DS, Qui M, Krishnaswamy G, Li C, and Stone W. Regulation of 
nitric oxide production from macrophages by lipopolysaccharide and 
catecholamines. Nitric Oxide 8: 127-132, 2003. 
13. Chopra M, Golden HB, Mullapudi S, Dowhan W, Dostal DE, and 
Sharma AC. Modulation of myocardial mitochondrial mechanisms during severe 
polymicrobial sepsis in the rat. PLoS One 6: e21285, 2011. 
14. Chopra M, and Sharma AC. Contractile response of norepinephrine is 
modulated by caspase-3 in adult rat ventricular myocytes isolated from septic rat 
heart. Pharmacol Res 60: 303-313, 2009. 
15. Chopra M, and Sharma AC. Distinct cardiodynamic and molecular 
characteristics during early and late stages of sepsis-induced myocardial 
dysfunction. Life Sci 81: 306-316, 2007. 
50 
 
16. Choy KW, Lau YS, Murugan D, Vanhoutte PM, and Mustafa MR. 
Paeonol Attenuates LPS-Induced Endothelial Dysfunction and Apoptosis by 
Inhibiting BMP4 and TLR4 Signaling Simultaneously but Independently. J 
Pharmacol Exp Ther 364: 420-432, 2018. 
17. Circu ML, and Aw TY. Reactive oxygen species, cellular redox systems, 
and apoptosis. Free Radic Biol Med 48: 749-762, 2010. 
18. Costa AD, Quinlan CL, Andrukhiv A, West IC, Jaburek M, and Garlid 
KD. The direct physiological effects of mitoK(ATP) opening on heart 
mitochondria. Am J Physiol Heart Circ Physiol 290: H406-415, 2006. 
19. D'Souza Y, Elharram A, Soon-Shiong R, Andrew RD, and Bennett BM. 
Characterization of Aldh2 (-/-) mice as an age-related model of cognitive 
impairment and Alzheimer's disease. Mol Brain 8: 27, 2015. 
20. de Punder K, and Pruimboom L. Stress induces endotoxemia and low-
grade inflammation by increasing barrier permeability. Front Immunol 6: 223, 
2015. 
21. Dewson G, and Kluck RM. Mechanisms by which Bak and Bax 
permeabilise mitochondria during apoptosis. J Cell Sci 122: 2801-2808, 2009. 
22. Doenst T, Nguyen TD, and Abel ED. Cardiac metabolism in heart failure: 
implications beyond ATP production. Circ Res 113: 709-724, 2013. 
23. Falschlehner C, Schaefer U, and Walczak H. Following TRAIL's path in 
the immune system. Immunology 127: 145-154, 2009. 
51 
 
24. Flores-Romero H, Garcia-Porras M, and Basanez G. Membrane 
insertion of the BAX core, but not latch domain, drives apoptotic pore formation. 
Sci Rep 7: 16259, 2017. 
25. Galloway CA, and Yoon Y. Mitochondrial dynamics in diabetic 
cardiomyopathy. Antioxid Redox Signal 22: 1545-1562, 2015. 
26. Garcia Bueno B, Caso JR, Madrigal JL, and Leza JC. Innate immune 
receptor Toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci 
Biobehav Rev 64: 134-147, 2016. 
27. Gillespie MN, Al-Mehdi AB, and McMurtry IF. Mitochondria in hypoxic 
pulmonary vasoconstriction: potential importance of compartmentalized reactive 
oxygen species signaling. Am J Respir Crit Care Med 187: 338-340, 2013. 
28. Gogvadze V, Robertson JD, Enoksson M, Zhivotovsky B, and 
Orrenius S. Mitochondrial cytochrome c release may occur by volume-
dependent mechanisms not involving permeability transition. Biochem J 378: 
213-217, 2004. 
29. Hu X, Yee E, Harlan JM, Wong F, and Karsan A. Lipopolysaccharide 
induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial 
cells. Blood 92: 2759-2765, 1998. 
30. Julien O, and Wells JA. Caspases and their substrates. Cell Death Differ 
24: 1380-1389, 2017. 
31. Kamisoglu K, Haimovich B, Calvano SE, Coyle SM, Corbett SA, 
Langley RJ, Kingsmore SF, and Androulakis IP. Human metabolic response 
52 
 
to systemic inflammation: assessment of the concordance between experimental 
endotoxemia and clinical cases of sepsis/SIRS. Crit Care 19: 71, 2015. 
32. Kern TS, Du Y, Miller CM, Hatala DA, and Levin LA. Overexpression of 
Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic 
retinopathy. Am J Pathol 176: 2550-2558, 2010. 
33. Kumari A, Iwasaki T, Pyndiah S, Cassimere EK, Palani CD, and 
Sakamuro D. Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation. 
Cell Death Differ 22: 311-322, 2015. 
34. Leipnitz G, Mohsen AW, Karunanidhi A, Seminotti B, Roginskaya VY, 
Markantone DM, Grings M, Mihalik SJ, Wipf P, Van Houten B, and Vockley 
J. Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-
mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients 
with complex I deficiency. Sci Rep 8: 1165, 2018. 
35. Li H, Cui H, Kundu TK, Alzawahra W, and Zweier JL. Nitric oxide 
production from nitrite occurs primarily in tissues not in the blood: critical role of 
xanthine oxidase and aldehyde oxidase. J Biol Chem 283: 17855-17863, 2008. 
36. Li M, Zhang P, Wei HJ, Li MH, Zou W, Li X, Gu HF, and Tang XQ. 
Hydrogen Sulfide Ameliorates Homocysteine-Induced Cognitive Dysfunction by 
Inhibition of Reactive Aldehydes Involving Upregulation of ALDH2. Int J 
Neuropsychopharmacol 20: 305-315, 2017. 
37. Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, and Musi N. 
Effect of lipopolysaccharide on inflammation and insulin action in human muscle. 
PLoS One 8: e63983, 2013. 
53 
 
38. Liu C, Stonestrom AJ, Christian T, Yong J, Takase R, Hou YM, and 
Yang X. Molecular Basis and Consequences of the Cytochrome c-tRNA 
Interaction. J Biol Chem 291: 10426-10436, 2016. 
39. Liu XR, Cao L, Li T, Chen LL, Yu YY, Huang WJ, Liu L, and Tan XQ. 
Propofol attenuates H2O2-induced oxidative stress and apoptosis via the 
mitochondria- and ER-medicated pathways in neonatal rat cardiomyocytes. 
Apoptosis 22: 639-646, 2017. 
40. Liu Y, and Chen XJ. Adenine nucleotide translocase, mitochondrial 
stress, and degenerative cell death. Oxid Med Cell Longev 2013: 146860, 2013. 
41. Lofrumento DD, La Piana G, Abbrescia DI, Palmitessa V, La Pesa V, 
Marzulli D, and Lofrumento NE. Valinomycin induced energy-dependent 
mitochondrial swelling, cytochrome c release, cytosolic NADH/cytochrome c 
oxidation and apoptosis. Apoptosis 16: 1004-1013, 2011. 
42. Malinska D, Mirandola SR, and Kunz WS. Mitochondrial potassium 
channels and reactive oxygen species. FEBS Lett 584: 2043-2048, 2010. 
43. McCommis KS, and Baines CP. The role of VDAC in cell death: friend or 
foe? Biochim Biophys Acta 1818: 1444-1450, 2012. 
44. McMurray F, Patten DA, and Harper ME. Reactive Oxygen Species and 
Oxidative Stress in Obesity-Recent Findings and Empirical Approaches. Obesity 
(Silver Spring) 24: 2301-2310, 2016. 
45. Meyrick B, Hoover R, Jones MR, Berry LC, Jr., and Brigham KL. In 
vitro effects of endotoxin on bovine and sheep lung microvascular and pulmonary 
artery endothelial cells. J Cell Physiol 138: 165-174, 1989. 
54 
 
46. Mula RV, Machiah D, Holland L, Wang X, Parihar H, Sharma AC, 
Selvaraj P, and Shashidharamurthy R. Immune Complex-Induced, Nitric 
Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented 
with Decoy FcgammaReceptors. PLoS One 11: e0153620, 2016. 
47. Nathan C, and Cunningham-Bussel A. Beyond oxidative stress: an 
immunologist's guide to reactive oxygen species. Nat Rev Immunol 13: 349-361, 
2013. 
48. Parthasarathy G, and Philipp MT. Review: apoptotic mechanisms in 
bacterial infections of the central nervous system. Front Immunol 3: 306, 2012. 
49. Raza H, John A, and Shafarin J. Potentiation of LPS-Induced Apoptotic 
Cell Death in Human Hepatoma HepG2 Cells by Aspirin via ROS and 
Mitochondrial Dysfunction: Protection by N-Acetyl Cysteine. PLoS One 11: 
e0159750, 2016. 
50. Rosadini CV, and Kagan JC. Early innate immune responses to bacterial 
LPS. Curr Opin Immunol 44: 14-19, 2017. 
51. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, and 
Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9: 
49-89, 2007. 
52. Sam AD, 2nd, Sharma AC, Law WR, and Ferguson JL. Splanchnic 
vascular control during sepsis and endotoxemia. Front Biosci 2: e72-92, 1997. 
53. Sam AD, 2nd, Sharma AC, Rice AN, Ferguson JL, and Law WR. 
Adenosine and nitric oxide regulate regional vascular resistance via 
55 
 
interdependent and independent mechanisms during sepsis. Crit Care Med 28: 
1931-1939, 2000. 
54. Shakeri R, Kheirollahi A, and Davoodi J. Apaf-1: Regulation and 
function in cell death. Biochimie 135: 111-125, 2017. 
55. Sharma AC. Sepsis-induced myocardial dysfunction. Shock 28: 265-269, 
2007. 
56. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, 
and Ferguson JL. Sepsis alters myocardial and plasma concentrations of 
endothelin and nitric oxide in rats. J Mol Cell Cardiol 29: 1469-1477, 1997. 
57. Sharma AC, Sam AD, 2nd, Lee LY, Hales DB, Law WR, Ferguson JL, 
and Bosmann HB. Effect of NG-nitro-L-arginine methyl ester on testicular blood 
flow and serum steroid hormones during sepsis. Shock 9: 416-421, 1998. 
58. Shioiri T, Muroi M, Hatao F, Nishida M, Ogawa T, Mimura Y, Seto Y, 
Kaminishi M, and Tanamoto K. Caspase-3 is activated and rapidly released 
from human umbilical vein endothelial cells in response to lipopolysaccharide. 
Biochim Biophys Acta 1792: 1011-1018, 2009. 
59. Shvetsova AN, Mennerich D, Keratar JM, Hiltunen JK, and Kietzmann 
T. Non-electron transfer chain mitochondrial defects differently regulate HIF-
1alpha degradation and transcription. Redox Biol 12: 1052-1061, 2017. 
60. Smith KA, Waypa GB, and Schumacker PT. Redox signaling during 
hypoxia in mammalian cells. Redox Biol 13: 228-234, 2017. 
56 
 
61. Snyder CM, Shroff EH, Liu J, and Chandel NS. Nitric oxide induces cell 
death by regulating anti-apoptotic BCL-2 family members. PLoS One 4: e7059, 
2009. 
62. Soufli I, Toumi R, Rafa H, and Touil-Boukoffa C. Overview of cytokines 
and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel 
diseases. World J Gastrointest Pharmacol Ther 7: 353-360, 2016. 
63. Suzuki Y, Hasegawa H, Tsuji T, Tsuruda K, Sasaki D, Ishihara K, 
Nagai K, Yanagihara K, Yamada Y, and Kamihira S. Relationships of diverse 
apoptotic death process patterns to mitochondrial membrane potential 
(Deltapsi(m)) evaluated by three-parameter flow cytometric analysis. 
Cytotechnology 65: 59-70, 2013. 
64. Um HD. Bcl-2 family proteins as regulators of cancer cell invasion and 
metastasis: a review focusing on mitochondrial respiration and reactive oxygen 
species. Oncotarget 7: 5193-5203, 2016. 
65. Wang C, and Youle RJ. The role of mitochondria in apoptosis*. Annu Rev 
Genet 43: 95-118, 2009. 
66. Wang Y, Wang Y, Yang D, Yu X, Li H, Lv X, Lu D, and Wang H. beta(1)-
adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis 
through activating PKA and enhancing CaMKII and IkappaBalpha 
phosphorylation. Crit Care 19: 76, 2015. 
67. Ward PA. Sepsis, apoptosis and complement. Biochem Pharmacol 76: 
1383-1388, 2008. 
57 
 
68. Wheeler DS. Death to sepsis: targeting apoptosis pathways in sepsis. Crit 
Care 13: 1010, 2009. 
69. Williams LJ, Nye BG, and Wende AR. Diabetes-Related Cardiac 
Dysfunction. Endocrinol Metab (Seoul) 32: 171-179, 2017. 
70. Yang X, Cohen MV, and Downey JM. Mechanism of cardioprotection by 
early ischemic preconditioning. Cardiovasc Drugs Ther 24: 225-234, 2010. 
71. Zhang M, Wang S, Cheng Z, Xiong Z, Lv J, Yang Z, Li T, Jiang S, Gu 
J, Sun D, and Fan Y. Polydatin ameliorates diabetic cardiomyopathy via Sirt3 
activation. Biochem Biophys Res Commun 493: 1280-1287, 2017. 
72. Zhang M, Zheng J, Nussinov R, and Ma B. Release of Cytochrome C 
from Bax Pores at the Mitochondrial Membrane. Sci Rep 7: 2635, 2017. 
73. Zhong H, Xiao M, Zarkovic K, Zhu M, Sa R, Lu J, Tao Y, Chen Q, Xia 
L, Cheng S, Waeg G, Zarkovic N, and Yin H. Mitochondrial control of apoptosis 
through modulation of cardiolipin oxidation in hepatocellular carcinoma: A novel 
link between oxidative stress and cancer. Free Radic Biol Med 102: 67-76, 2017. 
74. Ziello JE, Jovin IS, and Huang Y. Hypoxia-Inducible Factor (HIF)-1 
regulatory pathway and its potential for therapeutic intervention in malignancy 
and ischemia. Yale J Biol Med 80: 51-60, 2007. 
 
